Evidence map›Paper›PMID 42811008›Full record

ArticleBlood cancer journal2026

Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia.

Abiola Bolarinwa, Muhammad Yousuf, Aref Al-Kali, Hassan B Alkhateeb, Abhishek A Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Aasiya Matin, Michelle A Elliott, Mark R Litzow and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Abiola BolarinwaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5812-1954
Muhammad YousufDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Aref Al-KaliDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0824-3715
Hassan B AlkhateebDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Abhishek A MangaonkarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2458-9887
Antoine N SalibaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5134-7336
Mehrdad Hefazi TorghabehDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-8860-3380
Aasiya MatinDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Michelle A ElliottDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Mark R LitzowDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9816-6302
William J HoganDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5841-4105
Mithun V ShahDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5359-336X
Mrinal M PatnaikDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6998-662X
Animesh PardananiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Dong ChenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-7627-9560
Kaaren K ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5439-0778
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6116-8163
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9104-6172
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu.ORCID http://orcid.org/0000-0003-4605-3821
Kebede H BegnaDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2730-8593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42811008
PMCPMC13624261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.